Marrone Bio Innovations, Inc.
MBII
MBII was delisted on the 12th of July, 2022.
37 hedge funds and large institutions have $48.6M invested in Marrone Bio Innovations, Inc. in 2014 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 14 increasing their positions, 8 reducing their positions, and 15 closing their positions.
75% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 8
36% more capital invested
Capital invested by funds: $35.8M → $48.6M (+$12.8M)
24% less funds holding
Funds holding: 49 → 37 (-12)
67% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 15
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $7K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Senvest Management
New York
|
+$2.57M |
| 2 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
+$194K |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$172K |
| 4 |
State Street
Boston,
Massachusetts
|
+$79K |
| 5 |
AIG
American International Group
New York
|
+$60.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$790K |
| 2 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$420K |
| 3 |
OIM
Orca Investment Management
Roseburg,
Oregon
|
-$377K |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$334K |
| 5 |
CBOA
Commonwealth Bank of Australia
Sydney, NSW,
Australia
|
-$294K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Ameriprise
Minneapolis,
Minnesota
| – | -$1K | -250 | Closed |
|
MBII Hedge Fund Activity: Q4 2014 in Review
37 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in Marrone Bio Innovations, Inc. (MBII) for Q4 2014, worth a combined $48.6M — up 36% from $35.8M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of MBII and 5 opened new positions — a net loss of 10 holders — while 8 trimmed existing stakes and 14 added.
The largest buyer was Senvest Management, adding an estimated $2.57M. The largest seller was Gilder Gagnon Howe & Co, exiting entirely with an estimated $790K sold.
- 37 institutional investors held Marrone Bio Innovations, Inc. (MBII) as of Q4 2014, down from 49 in Q3 2014.
- Funds reported $48.6M of Marrone Bio Innovations, Inc. stock for Q4 2014, up 36% quarter-over-quarter.
- 5 funds opened new Marrone Bio Innovations, Inc. positions in Q4 2014 and 15 closed out, a net change of -10 holders.
- The largest Marrone Bio Innovations, Inc. buyer in Q4 2014 was Senvest Management, an estimated $2.57M added.
- The largest Marrone Bio Innovations, Inc. seller in Q4 2014 was Gilder Gagnon Howe & Co, an estimated $790K sold.
Based on aggregated 13F filings for Q4 2014.